Metastasis tumor-associated protein 2 enhances metastatic behavior and is associated with poor outcomes in estrogen receptor-negative breast cancer

By Covington Kyle   Brusco Lauren   Barone Ines   Tsimelzon Anna   Selever Jennifer   Corona-Rodriguez Arnoldo   Brown Powel   Kumar Rakesh   Hilsenbeck Susan   Fuqua Suzanne  

Breast Cancer Research and Treatment, Vol. 141, Iss. 3, 2013-10 ,pp. : 375-384

Springer Publishing Company

Access to resources Recommend Favorite

Presence of erbB2 mRNA in the plasma of breast cancer patients is associated with circulating tumor cells and negative estrogen and progesterone receptor status

By Xu Ye   Yao Lihua   Li Hongxia   Ouyang Tao   Li Jinfeng   Wang Tianfeng   Fan Zhaoqing   Lin Benyao   Lu Youyong   Larsson Olle   Xie Yuntao  

Breast Cancer Research and Treatment, Vol. 97, Iss. 1, 2006-05 ,pp. : 49-55

Springer Publishing Company

Access to resources Recommend Favorite

Estrogen receptor negative and progesterone receptor positive primary breast cancer: Pathological characteristics and clinical outcome

By Bernoux A.   de Cremoux P.   Lainé-Bidron C.   Martin E.C.   Asselain B.   Magdelénat H.  

Breast Cancer Research and Treatment, Vol. 49, Iss. 3, 1998-06 ,pp. : 219-225

Springer Publishing Company

Access to resources Recommend Favorite

Effects of obesity and race on prognosis in lymph node-negative, estrogen receptor-negative breast cancer

By Dignam James   Wieand Kelly   Johnson Karen   Raich Peter   Anderson Stewart   Somkin Carol   Wickerham D.  

Breast Cancer Research and Treatment, Vol. 97, Iss. 3, 2006-06 ,pp. : 245-254

Springer Publishing Company

Access to resources Recommend Favorite

Estrogen Receptor Negative and Progesterone Receptor Positive Breast Carcinomas—How Frequent are they?

By Cserni Gábor  

Pathology & Oncology Research, Vol. 17, Iss. 3, 2011-09 ,pp. : 663-668

Springer Publishing Company

Access to resources Recommend Favorite